Observational studyNeurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology2026
Changes in peripheral inflammatory cytokines and clinical outcomes before and after deep brain stimulation in patients with Parkinson's disease with or without type 2 diabetes mellitus: an observational study.
Observational study in Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundType 2 diabetes mellitus (T2DM) may influence clinical outcomes and inflammatory responses after deep brain stimulation (DBS) in patients with Parkinson's disease (PD). This study compared postoperative clinical and cytokine changes in patients with and without T2DM.
methodsThis observational study included 156 patients with PD undergoing first-time bilateral subthalamic nucleus DBS (78 with T2DM and 78 without T2DM). MDS-UPDRS III scores, levodopa equivalent daily dose (LEDD), Chinese Mini-Mental State Examination (CMMS) scores, BDI scores, and serum IL-1β, IL-10, and TNF-α levels were assessed before surgery and at 1 and 6 months after surgery. Exploratory analyses examined baseline HbA1c and individual cytokine trajectories.
resultsBefore surgery, the T2DM group had a higher BMI and LEDD and lower CMMS scores, whereas no statistically significant between-group differences were observed in Med OFF MDS-UPDRS III scores or cytokine levels. Both groups showed postoperative reductions in MDS-UPDRS III and LEDD. At 6 months, no statistically detectable between-group difference in motor improvement rate was observed (P = 0.667). Between-group cytokine change estimates were small, but 95% confidence intervals crossed zero and did not establish equivalence. Exploratory analyses did not identify clear associations of baseline HbA1c or individual cytokine trajectories with 6-month motor outcome.
conclusionsIn this selected cohort, T2DM was not associated with a statistically detectable reduction in short-term motor benefit after DBS. The observed cytokine changes were temporally associated with postoperative follow-up and should not be interpreted as evidence of a direct anti-inflammatory effect of DBS.
Indexed as
Identifiers
42747555What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.